Revenue | ₹1.29Cr |
Net Profits | ₹-1.36Cr |
Net Profit Margins | -105.43% |
Vanta Bioscience Ltd’s revenue fell -72.61% since last year same period to ₹1.29Cr in the Q4 2022-2023. On a quarterly growth basis, Vanta Bioscience Ltd has generated -54.42% fall in its revenue since last 3-months.
Vanta Bioscience Ltd’s net profit fell -2042.86% since last year same period to ₹-1.36Cr in the Q4 2022-2023. On a quarterly growth basis, Vanta Bioscience Ltd has generated 46.88% jump in its net profits since last 3-months.
Vanta Bioscience Ltd’s net profit margin fell -7193.69% since last year same period to -105.43% in the Q4 2022-2023. On a quarterly growth basis, Vanta Bioscience Ltd has generated -16.55% fall in its net profit margins since last 3-months.
The revenue for Vanta Bioscience Ltd in the Q4 results 2022 was ₹1.29Cr.
The net profit for Vanta Bioscience Ltd in the Q4 results 2022 was ₹-1.36Cr.
The net profit margin for Vanta Bioscience Ltd in the Q4 results 2022 was -105.43%.
The revenue for Vanta Bioscience Ltd in the Q4 results 2021 was ₹4.71Cr.
The net profit for Vanta Bioscience Ltd in the Q4 results 2021 was ₹0.07Cr.
The net profit margin for Vanta Bioscience Ltd in the Q4 results 2021 was 1.49%.